Brokerages Set Cigna Group (NYSE:CI) Target Price at $331.83

Cigna Group (NYSE:CI) has earned an average rating of “Moderate Buy” from the twenty-four ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation, nineteen have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $331.8261.

Several research analysts recently commented on the company. Barclays reduced their target price on Cigna Group from $383.00 to $300.00 and set an “overweight” rating for the company in a research report on Friday, October 31st. The Goldman Sachs Group reduced their price objective on shares of Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a report on Tuesday, November 4th. Wells Fargo & Company lowered their target price on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a research note on Wednesday, November 5th. UBS Group set a $294.00 price target on shares of Cigna Group in a research note on Wednesday, November 12th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $310.00 price objective on shares of Cigna Group in a report on Monday, November 3rd.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares in the company, valued at $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO David Cordani acquired 4,134 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, with a total value of $999,931.92. Following the acquisition, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Cigna Group

Several institutional investors have recently bought and sold shares of CI. Flaharty Asset Management LLC acquired a new stake in shares of Cigna Group in the first quarter valued at $28,000. 1248 Management LLC acquired a new stake in Cigna Group in the 1st quarter valued at about $29,000. Solstein Capital LLC bought a new position in shares of Cigna Group in the second quarter worth about $29,000. Harbor Capital Advisors Inc. lifted its position in shares of Cigna Group by 119.5% during the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after purchasing an additional 49 shares in the last quarter. Finally, Chilton Capital Management LLC bought a new stake in shares of Cigna Group during the second quarter valued at approximately $30,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Down 0.5%

NYSE CI opened at $275.06 on Monday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The stock has a market cap of $73.48 billion, a PE ratio of 12.13, a PEG ratio of 1.00 and a beta of 0.26. The firm has a 50-day simple moving average of $273.35 and a 200 day simple moving average of $290.60. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, beating the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The firm had revenue of $69.57 billion during the quarter, compared to analysts’ expectations of $66.40 billion. During the same quarter in the prior year, the firm posted $7.51 EPS. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th were given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Thursday, December 4th. Cigna Group’s dividend payout ratio is 26.64%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.